Peak XV is poised to benefit significantly from the upcoming public market debuts of several high-profile companies, including Groww, Pine Labs, Wakefit, and Meesho, with Groww representing the largest potential payday as Peak XV plans to sell up to 158.3 million shares, reducing its stake by 2.6%.

Pine Labs, a digital payments platform, is planning a $1 billion IPO, with Peak XV holding over 20% and expected to sell up to 39 million shares, which would decrease its stake by approximately 3.6%.

This year, the firm has experienced leadership changes, including the departure of three managing directors, and has revised its fund management fee structure from 2.5/30 to 2/20, with a possible carry increase to 30%, reflecting strategic adjustments amid its IPO activities.

Beyond upcoming IPOs, Peak XV has already realized gains from investments like Bluestone, which went public in August with a Rs 1,540 crore IPO, increasing Peak XV's stake value from under Rs 2,400 crore due to stock appreciation.

As a venture capital firm spun out of Sequoia Capital two years ago, Peak XV is approaching a period of substantial financial gains driven by the IPOs of its portfolio companies.

Peak XV also holds a 13.6% stake in Meesho, which has filed papers to raise Rs 4,250 crore, potentially leading to further gains for the firm.

Groww, a popular discount brokerage among retail investors, has filed for an IPO targeting a Rs 6,000-7,000 crore valuation, with Peak XV holding nearly 20% of the company, purchased at Rs 1.91 per share, which could yield an exit nearly twice that amount.

Wakefit, a direct-to-consumer mattress maker, plans to raise Rs 468 crore, with Peak XV holding 22.7% and planning to sell up to 7.7% of its stake at an entry price of Rs 20.52 per share, promising an exit return four times higher than its second-largest investor.